{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:45:22Z","timestamp":1793598322764,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7759","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41586-019-1215-2","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T14:04:47Z","timestamp":1557929087000},"page":"112-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy"],"prefix":"10.1038","volume":"570","author":[{"given":"Mauro","family":"Di Pilato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno L.","family":"Cadilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper N.","family":"Pr\u00fc\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen N.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Seruggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq M.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Misale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zappulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Carrizosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinidhra","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ligorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Medoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra-Chloe","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten R.","family":"Mempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"1215_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/imr.12166","volume":"259","author":"PA Savage","year":"2014","unstructured":"Savage, P. A., Leventhal, D. S. & Malchow, S. Shaping the repertoire of tumor-infiltrating effector and regulatory T cells. Immunol. Rev. 259, 245\u2013258 (2014).","journal-title":"Immunol. Rev."},{"key":"1215_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480\u2013489 (2011).","journal-title":"Nature"},{"key":"1215_CR3","doi-asserted-by":"publisher","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","volume":"5","author":"S Spranger","year":"2013","unstructured":"Spranger, S. et al. Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells. Sci. Transl. Med. 5, 200ra116 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1215_CR4","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1172\/JCI66375","volume":"124","author":"CA Bauer","year":"2014","unstructured":"Bauer, C. A. et al. Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. J. Clin. Invest. 124, 2425\u20132440 (2014).","journal-title":"J. Clin. Invest."},{"key":"1215_CR5","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1515\/hsz-2016-0216","volume":"397","author":"I Meininger","year":"2016","unstructured":"Meininger, I. & Krappmann, D. Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome. Biol. Chem. 397, 1315\u20131333 (2016).","journal-title":"Biol. Chem."},{"key":"1215_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/eji.200838734","volume":"39","author":"BD Medoff","year":"2009","unstructured":"Medoff, B. D. et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39, 78\u201384 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1215_CR7","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.4049\/jimmunol.0900498","volume":"182","author":"LL Molinero","year":"2009","unstructured":"Molinero, L. L. et al. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J. Immunol. 182, 6736\u20136743 (2009).","journal-title":"J. Immunol."},{"key":"1215_CR8","doi-asserted-by":"publisher","first-page":"e1000051","DOI":"10.1371\/journal.pbio.1000051","volume":"7","author":"MJ Barnes","year":"2009","unstructured":"Barnes, M. J. et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7, e1000051 (2009).","journal-title":"PLoS Biol."},{"key":"1215_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/cdd.2015.104","volume":"24","author":"A Br\u00fcstle","year":"2017","unstructured":"Br\u00fcstle, A. et al. MALT1 is an intrinsic regulator of regulatory T cells. Cell Death Differ. 24, 1214\u20131223 (2017).","journal-title":"Cell Death Differ."},{"key":"1215_CR10","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1073\/pnas.0400885101","volume":"101","author":"M Schmidt-Supprian","year":"2004","unstructured":"Schmidt-Supprian, M. et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-\u03baB activation. Proc. Natl Acad. Sci. USA 101, 4566\u20134571 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1215_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1084\/jem.20131142","volume":"211","author":"KS Smigiel","year":"2014","unstructured":"Smigiel, K. S. et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211, 121\u2013136 (2014).","journal-title":"J. Exp. Med."},{"key":"1215_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.immuni.2009.09.022","volume":"31","author":"M Long","year":"2009","unstructured":"Long, M., Park, S.-G., Strickland, I., Hayden, M. S. & Ghosh, S. Nuclear factor-\u03baB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31, 921\u2013931 (2009).","journal-title":"Immunity"},{"key":"1215_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2017.08.010","volume":"47","author":"H Oh","year":"2017","unstructured":"Oh, H. et al. An NF-\u03baB transcription-factor-dependent lineage-specific transcriptional program promotes regulatory T cell identity and function. Immunity 47, 450\u2013465.e5 (2017).","journal-title":"Immunity"},{"key":"1215_CR14","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1016\/j.celrep.2017.08.068","volume":"20","author":"A Vasanthakumar","year":"2017","unstructured":"Vasanthakumar, A. et al. The TNF receptor superfamily-NF-\u03baB axis is critical to maintain effector regulatory T cells in lymphoid and non-lymphoid tissues. Cell Rep. 20, 2906\u20132920 (2017).","journal-title":"Cell Rep."},{"key":"1215_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2016.03.017","volume":"70","author":"N Messina","year":"2016","unstructured":"Messina, N. et al. The NF-\u03baB transcription factor RelA is required for the tolerogenic function of Foxp3+ regulatory T cells. J. Autoimmun. 70, 52\u201362 (2016).","journal-title":"J. Autoimmun."},{"key":"1215_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cell.2017.08.004","volume":"170","author":"Y Grinberg-Bleyer","year":"2017","unstructured":"Grinberg-Bleyer, Y. et al. NF-\u03baB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer. Cell 170, 1096\u20131108.e13 (2017).","journal-title":"Cell"},{"key":"1215_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7074","volume":"6","author":"J Yu","year":"2015","unstructured":"Yu, J. et al. Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat. Commun. 6, 6074 (2015).","journal-title":"Nat. Commun."},{"key":"1215_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/pcmr.12220","volume":"27","author":"MH Jenkins","year":"2014","unstructured":"Jenkins, M. H. et al. Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res. 27, 495\u2013501 (2014).","journal-title":"Pigment Cell Melanoma Res."},{"key":"1215_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ni.2649","volume":"14","author":"W Pierson","year":"2013","unstructured":"Pierson, W. et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells. Nat. Immunol. 14, 959\u2013965 (2013).","journal-title":"Nat. Immunol."},{"key":"1215_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe, A. E. et al. Interferon-\u03b3 drives Treg fragility to promote anti-tumor immunity. Cell 169, 1130\u20131141.e11 (2017).","journal-title":"Cell"},{"key":"1215_CR21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","volume":"9","author":"A Gewies","year":"2014","unstructured":"Gewies, A. et al. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. Cell Reports 9, 1292\u20131305 (2014).","journal-title":"Cell Reports"},{"key":"1215_CR22","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.15252\/embj.201488987","volume":"33","author":"M Jaworski","year":"2014","unstructured":"Jaworski, M. et al. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. EMBO J. 33, 2765\u20132781 (2014).","journal-title":"EMBO J."},{"key":"1215_CR23","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.4049\/jimmunol.1402254","volume":"194","author":"F Bornancin","year":"2015","unstructured":"Bornancin, F. et al. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation. J. Immunol. 194, 3723\u20133734 (2015).","journal-title":"J. Immunol."},{"key":"1215_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","volume":"22","author":"D Nagel","year":"2012","unstructured":"Nagel, D. et al. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell 22, 825\u2013837 (2012).","journal-title":"Cancer Cell"},{"key":"1215_CR25","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.1002\/anie.201304290","volume":"52","author":"F Schlauderer","year":"2013","unstructured":"Schlauderer, F. et al. Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase. Angew. Chem. Int. Edn Engl. 52, 10384\u201310387 (2013).","journal-title":"Angew. Chem. Int. Edn Engl."},{"key":"1215_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","volume":"22","author":"L Fontan","year":"2012","unstructured":"Fontan, L. et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell 22, 812\u2013824 (2012).","journal-title":"Cancer Cell"},{"key":"1215_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.68","volume":"6","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. MALT1 promotes melanoma progression through JNK\/c-Jun signaling. Oncogenesis 6, e365 (2017).","journal-title":"Oncogenesis"},{"key":"1215_CR28","doi-asserted-by":"publisher","first-page":"a003004","DOI":"10.1101\/cshperspect.a003004","volume":"2","author":"M Thome","year":"2010","unstructured":"Thome, M., Charton, J. E., Pelzer, C. & Hailfinger, S. Antigen receptor signaling to NF-\u03baB via CARMA1, BCL10, and MALT1. Cold Spring Harb. Perspect. Biol. 2, a003004\u2013a003004 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1215_CR29","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1215_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"1215_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1215_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546\u2013558 (2008).","journal-title":"Immunity"},{"key":"1215_CR33","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"1215_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-213X-1-4","volume":"1","author":"S Srinivas","year":"2001","unstructured":"Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).","journal-title":"BMC Dev. Biol."},{"key":"1215_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2006.04.005","volume":"24","author":"Y Sasaki","year":"2006","unstructured":"Sasaki, Y. et al. Canonical NF-\u03baB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729\u2013739 (2006).","journal-title":"Immunity"},{"key":"1215_CR36","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1126\/science.8456300","volume":"259","author":"DK Dalton","year":"1993","unstructured":"Dalton, D. K. et al. Multiple defects of immune cell function in mice with disrupted interferon-\u03b3 genes. Science 259, 1739\u20131742 (1993).","journal-title":"Science"},{"key":"1215_CR37","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1073\/pnas.88.13.5528","volume":"88","author":"VL Godfrey","year":"1991","unstructured":"Godfrey, V. L., Wilkinson, J. E., Rinchik, E. M. & Russell, L. B. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl Acad. Sci. USA 88, 5528\u20135532 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1215_CR38","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0960-9822(03)00491-3","volume":"13","author":"T Egawa","year":"2003","unstructured":"Egawa, T. et al. Requirement for CARMA1 in antigen receptor-induced NF-\u03baB activation and lymphocyte proliferation. Curr. Biol. 13, 1252\u20131258 (2003).","journal-title":"Curr. Biol."},{"key":"1215_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2012.09.012","volume":"38","author":"F Marangoni","year":"2013","unstructured":"Marangoni, F. et al. The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. Immunity 38, 237\u2013249 (2013).","journal-title":"Immunity"},{"key":"1215_CR40","first-page":"1067","volume":"79","author":"PJ Spiess","year":"1987","unstructured":"Spiess, P. J., Yang, J. C. & Rosenberg, S. A. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J. Natl. Cancer Inst. 79, 1067\u20131075 (1987).","journal-title":"J. Natl. Cancer Inst."},{"key":"1215_CR41","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.4049\/jimmunol.1701220","volume":"200","author":"F Marangoni","year":"2018","unstructured":"Marangoni, F. et al. Tumor tolerance-promoting function of regulatory T cells is optimized by CD28, but strictly dependent on calcineurin. J. Immunol. 200, 3647\u20133661 (2018).","journal-title":"J. Immunol."},{"key":"1215_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1215_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"1215_CR44","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1215-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:55:45Z","timestamp":1684605345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":44,"journal-issue":{"issue":"7759","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1215-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735764048.793563876","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.735764048.793560813","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"15 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D.P. and T.R.M. have filed a patent application (PCT\/US2018\/067856) related to the use of MALT1 inhibitors. T.R.M. is a co-founder of Monopteros Therapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}